SecurityPXI / PowerShares Exchange-Trade Fund Trust (73935X385)
Institutional Owners6
Institutional Shares28,516
Institutional Value$ 1,102,000 USD

Institutional Stock Ownership and Shareholders

PowerShares Exchange-Trade Fund Trust (NASDAQ:PXI) has 6 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 28,516 shares. Largest shareholders include McKinley Carter Wealth Services, Inc., Hsbc Holdings Plc, Citigroup Inc, MetLife Securities, Inc, Ladenburg Thalmann Financial Services Inc, and WFG Advisors, LP.
PowerShares Exchange-Trade Fund Trust (NASDAQ:PXI) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-08-14 13F-HR JP Morgan Chase & Co 26 0 -100.00 1 0 -100.00
2018-08-14 13F-HR AMERIPRISE FINANCIAL INC 10,337 0 -100.00 399 0 -100.00
2018-08-14 13F-HR UBS Group AG 6,224 0 -100.00 236 0 -100.00
2018-05-11 13F-HR HSBC HOLDINGS PLC 7,600 7,600 0.00 300 288 -4.00
2018-08-14 13F-HR CLS Investments, LLC 9 0 -100.00 0 0
2018-07-20 13F-HR Steward Partners Investment Advisory, Llc 1,000 0 -100.00 37 0 -100.00
2018-08-14 13F-HR ROYAL BANK OF CANADA 13,643 0 -100.00 517 0 -100.00
2018-08-15 13F-HR JANE STREET GROUP, LLC 40,980 0 -100.00 1,553 0 -100.00
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 65,608 0 -100.00 2,487 0 -100.00
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 14,658 0 -100.00 556 0 -100.00
2018-08-14 13F-HR UNITED CAPITAL FINANCIAL ADVISERS, LLC 5,734 0 -100.00 217 0 -100.00
2018-08-14 13F-HR MILLENNIUM MANAGEMENT LLC 15,773 0 -100.00 599 0 -100.00
2017-08-18 13F-HR WFG Advisors, LP 12,792 400 -96.87 499 13 -97.39
2018-08-13 13F-HR BLAIR WILLIAM & CO/IL 45 0 -100.00 2 0 -100.00
2018-08-13 13F-HR MML INVESTORS SERVICES, LLC 5,555 0 -100.00 211 0 -100.00
2018-08-14 13F-HR Tower Research Capital LLC (TRC) 53 0 -100.00 2 0 -100.00
2018-08-14 13F-HR MORGAN STANLEY 84,045 0 -100.00 3,186 0 -100.00
2018-08-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 1,550 1,550 0.00 59 59 0.00
2018-08-10 13F-HR CITIGROUP INC 4,000 0 -100.00 152 0 -100.00
2018-07-18 13F-HR Bedel Financial Consulting, Inc. 2,600 0 -100.00 99 0 -100.00
2018-08-13 13F-HR Advisor Group, Inc. 3,395 0 -100.00 128 0 -100.00
2018-08-10 13F-HR Acorn Wealth Advisors, Llc 185 0 -100.00 8 0 -100.00
2018-08-09 13F-HR Gradient Investments LLC 155 0 -100.00 6 0 -100.00
2018-08-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 13,482 0 -100.00 512 0 -100.00
2018-08-14 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 42 0 -100.00 2 0 -100.00
2018-05-11 13F-HR CITIGROUP INC 4,103 4,000 -2.51 162 152 -6.17
2018-07-31 13F-HR Commonwealth Equity Services, Llc. 65,418 0 -100.00 2,479 0 -100.00
2018-07-26 13F-HR MURPHY CAPITAL MANAGEMENT INC 9,417 0 -100.00 356 0 -100.00
2017-01-13 13F-HR MetLife Securities, Inc 3,757 3,966 5.56 156 173 10.90
2018-08-10 13F-HR HSBC HOLDINGS PLC 7,600 0 -100.00 288 0 -100.00
2018-02-16 13F-HR/A Commonwealth Equity Services, Inc 6,031 0 -100.00 202 0 -100.00
2018-08-10 13F-HR Cambridge Investment Research Advisors, Inc. 8,305 0 -100.00 315 0 -100.00
2018-08-10 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 285 0 -100.00 11 0 -100.00
2018-05-17 13F-HR McKinley Carter Wealth Services, Inc. 15,315 11,000 -28.17 605 417 -31.07
2018-08-14 13F-HR LPL Financial LLC 17,016 0 -100.00 645 0 -100.00
2018-08-07 13F-HR Essex Financial Services, Inc. 5,848 0 -100.00 222 0 -100.00
2018-07-30 13F-HR Raymond James Financial Services Advisors, Inc. 32,289 0 -100.00 1,224 0 -100.00
2018-07-11 13F-HR Atlas Brown,Inc. 8,338 0 -100.00 316 0 -100.00
2018-08-14 13F-HR Parallax Volatility Advisers, L.P. 1 0 -100.00 0 0

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Related News Stories

Best Energy ETFs and Stocks of Last Week

2018-08-27 investorplace
U.S. crude bounced back nicely and recorded its weekly gain in two months ending their longest run of weekly losses since 2015. This is primarily thanks to the tightening supply outlook on the back of looming Iranian supply shortages, and a strike in the North Sea oil and gas fields amid rising U.S. oil production. (12-0)

Energy and Technology: 2 ETFs to Watch on Outsized Volume

2018-04-06 investorplace
In the last trading session, U.S. stocks climbed on easing fears of trade tensions and a rebound in technology stocks. Among the top ETFs, investors saw SPY gain 1.15%, DIA rise 0.91%, and QQQ move higher by 1.58% on the day.

CUSIP: 73935X385